Add to ORKGThe Author(s) 2015. This article is published with open access at Springerlink.com Objectives: Metformin is the first-line therapy for most patients with type 2 diabetes, but the majority require treatment intensification at some stage due to the progressive nature of the disease. The 1860-LIRA-DPP-4 trial showed that liraglutide exhibited greater improvements compared with sitagliptin in glycated hemoglobin and body mass index in patients with type 2 diabetes inadequately controlled on metformin monotherapy. As a follow-up to a previously published cost-effectiveness analysis of 1.2 mg liraglutide versus sitagliptin in Spain, the aim of this analysis was to compare long
Introduction: The aim of the present study was to use real-world data from Swedish primary-care and ...
The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: Lin...
Abstract Objective: To evaluate long-run cost-effectiveness in a Swedish setting for liraglutide com...
The Author(s) 2013. This article is published with open access at Springerlink.com Introduction: Tre...
The Author(s) 2014. This article is published with open access at Springerlink.com Introduction: Thi...
Glucagon-like peptide-1 (GLP-1) receptor agonists are used successfully in the treatment of patients...
P>Aim: The aim of this study was to compare the efficacy and safety of once-daily human glucagon-lik...
AIM: The aim of this study was to compare the efficacy and safety of once-daily human glucagon-like ...
The Author(s) 2014. This article is published with open access at Springerlink.com Introduction: Cli...
Item does not contain fulltextBACKGROUND: Addition of the GLP-1 receptor agonist liraglutide to insu...
<div><p>Background</p><p>We assessed the cost-effectiveness of the glucagon-like peptide 1 receptor ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
BACKGROUND: Agonists of the glucagon-like peptide-1 (GLP-1) receptor provide pharmacological levels...
Introduction: A cost-effectiveness analysis was conducted comparing a fixed-ratio combination (FRC) ...
We assessed the cost-effectiveness of the glucagon-like peptide 1 receptor agonists liraglutide 1.8 ...
Introduction: The aim of the present study was to use real-world data from Swedish primary-care and ...
The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: Lin...
Abstract Objective: To evaluate long-run cost-effectiveness in a Swedish setting for liraglutide com...
The Author(s) 2013. This article is published with open access at Springerlink.com Introduction: Tre...
The Author(s) 2014. This article is published with open access at Springerlink.com Introduction: Thi...
Glucagon-like peptide-1 (GLP-1) receptor agonists are used successfully in the treatment of patients...
P>Aim: The aim of this study was to compare the efficacy and safety of once-daily human glucagon-lik...
AIM: The aim of this study was to compare the efficacy and safety of once-daily human glucagon-like ...
The Author(s) 2014. This article is published with open access at Springerlink.com Introduction: Cli...
Item does not contain fulltextBACKGROUND: Addition of the GLP-1 receptor agonist liraglutide to insu...
<div><p>Background</p><p>We assessed the cost-effectiveness of the glucagon-like peptide 1 receptor ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
BACKGROUND: Agonists of the glucagon-like peptide-1 (GLP-1) receptor provide pharmacological levels...
Introduction: A cost-effectiveness analysis was conducted comparing a fixed-ratio combination (FRC) ...
We assessed the cost-effectiveness of the glucagon-like peptide 1 receptor agonists liraglutide 1.8 ...
Introduction: The aim of the present study was to use real-world data from Swedish primary-care and ...
The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: Lin...
Abstract Objective: To evaluate long-run cost-effectiveness in a Swedish setting for liraglutide com...